Cliniques Universitaires Saint-Luc Brussels

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer	Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder	Active, not recruiting	Not applicable	2026-02-09		NCT02308085
Phase II RAINSPOT: Zolbetuximab-Paclitaxel-Ramucirumab for CLDN18.2 Positive Gastro-esophageal Cancer	Gastric Adenocarcinoma and Gastroesophageal Junction Adenocarcinoma; Gastric Cancer Adenocarcinoma Metastatic	Recruiting	Phase 2	2025-12-22		NCT06962137

Clinical trials